Cumberland Pharmaceuticals (CPIX) Capital Expenditures (QoQ) (2010 - 2025)
Cumberland Pharmaceuticals (CPIX) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -100.00% |
| Sep 30, 2025 | -10.19% |
| Jun 30, 2025 | -44.39% |
| Mar 31, 2025 | 1,986.29% |
| Dec 31, 2024 | -85.16% |
| Sep 30, 2024 | 114.25% |
| Jun 30, 2024 | -82.75% |
| Mar 31, 2024 | -14.49% |
| Dec 31, 2023 | -8.41% |
| Sep 30, 2023 | -26.39% |
| Jun 30, 2023 | -32.69% |
| Mar 31, 2023 | 169.86% |
| Dec 31, 2022 | -267.91% |
| Sep 30, 2022 | -33.38% |
| Jun 30, 2022 | 408.62% |
| Mar 31, 2022 | 198.29% |
| Dec 31, 2021 | -84.91% |
| Sep 30, 2021 | 297.76% |
| Jun 30, 2021 | -22.54% |
| Mar 31, 2021 | -57.36% |